Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          

SB02

SB02

SB02 is a new chemical entity with oral activity and proven with multiple anti-cancer MOA.

Request for Collaboration
Overview
SB02 is a new drug originated in Taiwan, from discovery, research and development, preclinical ADME.
  • SB02 is an oral active anti-tumor drug NCE
  • Proven with multiple anti-cancer MOA
  • Ready for IND
Collaboration Options
  • Co-develop
  • Tech transfer
  • Licensing
People who like this also like
  • Decellularization matrixDecellularization matrix
  • FB825FB825
  • Isoniazid without liver toxicityIsoniazid without liver toxicity
  • PHN014 (Acute ischemia stroke)PHN014 (Acute ischemia stroke)
  • Zwitterionic interface processing technologyZwitterionic interface processing technology
  • New Chemical Entities - NCENew Chemical Entities - NCE
  • FuraprevirFuraprevir
  • Stabilized Injectable Formulation - SIFStabilized Injectable Formulation - SIF
  • FLISA (IgE/IgG test)FLISA (IgE/IgG test)
  • Injectable Manufacturing ServicesInjectable Manufacturing Services